Brean Capital Starts Endocyte (ECYT) at Buy
Tweet Send to a Friend
Brean Capital initiates coverage on Endocyte (NASDAQ: ECYT) with a Buy rating and a price target of $21.00.
"ECYT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
"ECYT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE